Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
0.6200
-0.0975 (-13.59%)
At close: Apr 1, 2025, 4:00 PM
0.6490
+0.0290 (4.68%)
After-hours: Apr 1, 2025, 7:47 PM EDT

Vor Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Net Income
-116.91-117.86-92.09-68.9-43.34
Upgrade
Depreciation & Amortization
3.533.492.531.430.61
Upgrade
Loss (Gain) From Sale of Assets
-0.02----
Upgrade
Stock-Based Compensation
9.8513.3610.74.321.34
Upgrade
Other Operating Activities
3.890.073.573.190.78
Upgrade
Change in Accounts Payable
2.242.851.110.415.82
Upgrade
Change in Other Net Operating Assets
-2.24-2.2-10.95-9.59-1.5
Upgrade
Operating Cash Flow
-99.66-100.29-85.14-69.14-36.29
Upgrade
Capital Expenditures
-0.23-1.07-8.46-3.89-4.16
Upgrade
Investment in Securities
97.0972.08-85.63-87.76-
Upgrade
Investing Cash Flow
96.8671.01-94.09-91.65-4.16
Upgrade
Issuance of Common Stock
56.054.84117.14189.750.26
Upgrade
Repurchase of Common Stock
-0.33-1.19---
Upgrade
Other Financing Activities
-2.33-0.72--2.22-
Upgrade
Financing Cash Flow
53.392.94117.14232.9182.53
Upgrade
Net Cash Flow
50.59-26.35-62.172.1242.07
Upgrade
Free Cash Flow
-99.89-101.36-93.61-73.04-40.45
Upgrade
Free Cash Flow Per Share
-1.45-1.51-2.37-2.19-189.34
Upgrade
Levered Free Cash Flow
-60.89-58.02-51.87-48.67-21.65
Upgrade
Unlevered Free Cash Flow
-60.89-58.02-51.87-48.67-21.65
Upgrade
Change in Net Working Capital
-1.7-4.97-1.767.39-7.66
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q